跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sinurin tablets - NPRA Drug Approval Details
Approvals
/
NPRA
/
Sinurin tablets
Approved
STANDARD
Sinurin tablets
PRIME PHARMACEUTICAL SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
b437df4af8588d46
Company
PRIME PHARMACEUTICAL SDN. BHD.
Type
Standard
Approval Details
Approval Id
b437df4af8588d46
Drug Approval Npra Name
Sinurin tablets
Product Name
Sinurin tablets
Registration Number
MAL17025023AZ
Holder Company Name
PRIME PHARMACEUTICAL SDN. BHD.
Holder Address
1505, LORONG PERUSAHAAN UTAMA 1 TAMAN PERINDUSTRIAN BUKIT TENGAH 14000 BUKIT MERTAJAM MALAYSIA
Holder Phone
04-5074787
Manufacturer Company Name
PRIME PHARMACEUTICAL SDN. BHD.
Manufacturer Address
1505, LORONG PERUSAHAAN UTAMA 1 TAMAN PERINDUSTRIAN BUKIT TENGAH 14000 BUKIT MERTAJAM MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL17025023AZ
Version
1751614576
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
b437df4af8588d46
Type
Standard
Source
Official Source
Back to NPRA Approvals